Literature DB >> 24265903

Immunohistochemical clue for the histological overlap of salivary adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma.

Sherif El-Nagdy1, Naglaa M Salama, Mohamed I Mourad.   

Abstract

It remains difficult to distinguish adenoid cystic carcinoma (ACC) from polymorphous low-grade adenocarcinoma (PLGA). Although these neoplasms exhibit nearly similar histologic patterns, their biologic behavior is significantly different. This study was carried out in an attempt to overcome the histological overlap between these tumors using immunohistochemical method for c-kit and galectin-3 proteins on twenty cases of salivary gland tumors including twelve ACC and eight PLGA. Results revealed positive cytoplasmic reactivity for c-kit in 100% of ACC cases and only in 25% of PLGA. On the other hand, galectin-3 expression was observed in 100% of both ACC and PLGA cases. Moreover, solid variant of ACC showed overexpression of both proteins than cribriform and tubular subtypes. Significant positive correlation between the two studied proteins in ACC and PLGA was also observed (p < 0.05). Upon these results, over expression of c-kit and galectin-3 in ACC cases supports the concept of solid variant as a high-grade tumor. Moreover, c-kit may be used as a helpful marker to distinguish ACC from PLGA in cases where the diagnosis can be challenging.

Entities:  

Keywords:  adenoid cystic carcinoma (ACC); c-kit; galectin-3; polymorphous low-grade adenocarcinoma (PLGA)

Year:  2013        PMID: 24265903      PMCID: PMC3831811          DOI: 10.1556/IMAS.5.2013.3.6

Source DB:  PubMed          Journal:  Interv Med Appl Sci        ISSN: 2061-1617


  56 in total

Review 1.  Galectin-3 as a multifunctional protein.

Authors:  Anna Krześlak; Anna Lipińska
Journal:  Cell Mol Biol Lett       Date:  2004       Impact factor: 5.787

2.  Decreased expression of galectin-3 is associated with progression of human breast cancer.

Authors:  V Castronovo; F A Van Den Brûle; P Jackers; N Clausse; F T Liu; C Gillet; M E Sobel
Journal:  J Pathol       Date:  1996-05       Impact factor: 7.996

Review 3.  Adenoid cystic carcinoma of the head and neck. Clinicopathological analysis of 23 patients and review of the literature.

Authors:  Alexander D Rapidis; Nikolaos Givalos; Hariklia Gakiopoulou; Gregory Faratzis; Spyros D Stavrianos; George A Vilos; Emmanuel E Douzinas; Efstratios Patsouris
Journal:  Oral Oncol       Date:  2005-03       Impact factor: 5.337

4.  Clinical significance of Galectin-3 in clear cell renal cell carcinoma.

Authors:  Manabu Sakaki; Tomoharu Fukumori; Tomoya Fukawa; Essam Elsamman; Avirmed Shiirevnyamba; Hiroyoshi Nakatsuji; Hiro-omi Kanayama
Journal:  J Med Invest       Date:  2010-02

5.  Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma.

Authors:  Y Honjo; H Inohara; S Akahani; T Yoshii; Y Takenaka; J Yoshida; K Hattori; Y Tomiyama; A Raz; T Kubo
Journal:  Clin Cancer Res       Date:  2000-12       Impact factor: 12.531

6.  KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma.

Authors:  V A Holst; C E Marshall; C A Moskaluk; H F Frierson
Journal:  Mod Pathol       Date:  1999-10       Impact factor: 7.842

Review 7.  Galectins. Structure and function of a large family of animal lectins.

Authors:  S H Barondes; D N Cooper; M A Gitt; H Leffler
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

8.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

9.  Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications.

Authors:  X C Xu; A K el-Naggar; R Lotan
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

Review 10.  Adenoid cystic carcinoma of the head and neck--a 20 years experience.

Authors:  H Kokemueller; A Eckardt; P Brachvogel; J-E Hausamen
Journal:  Int J Oral Maxillofac Surg       Date:  2004-01       Impact factor: 2.789

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.